Report Overview

Juniper Research’s latest Digital Therapeutics & Wellness research report offers in-depth assessment of this fast-changing market; providing critical insights into the key stakeholders powering the digital therapeutics and wellness ecosystem, as well as appraising the business models driving growth globally.

The report also provides an in-depth analysis of the drivers, developments, and challenges shaping the market, plus detailed analysis and forecasts for the following key segments:

  • Asthma & COPD Therapeutics
  • CVD & Hypertension Therapeutics
  • Diabetes Therapeutics
  • Physical Therapy Therapeutics
  • Smoking Cessation Therapeutics
  • Weight Management Therapeutics
  • Consumer Digital Wellness Apps
  • Corporate Digital Wellness Programmes

The research also contains a 15-vendor Juniper Research Competitor Leaderboard, which positions key vendors on their relative strengths, accompanied by individual profiles appraising each vendor’s respective offerings, and providing personalised recommendations for success.

This research suite includes:

  • Market Strategies & Trends (PDF)
  • Market Data & Forecasting (PDF)
  • Competitor Leaderboard (PDF)
  • 12 Months’ Access to harvest Online Data Platform
Key Market Statistics
Market size in 2022: $6.5bn
Market size in 2026: $28.0bn
2022 to 2026 CAGR: 42.12%

  Buy Full Research Suite - Immediate access to all the above only £3750.


Key Features

  • Ecosystem Analysis: An insightful analysis of the digital therapeutics and wellness value chains; covering key stakeholders including:
    • Product Vendors
    • Systems Integrators
    • Regulatory Bodies
    • Clinicians & Employers
    • Health Insurers
  • Business Models: A detailed appraisal of monetisation practices used by stakeholders within the digital therapeutics and wellness value chains, in particular:
    • How these models are evolving with the maturation of the market.
    • What challenges stakeholders must overcome if widespread adoption of these technologies is to be achieved.
  • Juniper Research Competitor Leaderboard: 15 players compared, scored, and positioned on the Juniper Research Competitor Leaderboard, including:
    • 2Morrow
    • Big Health
    • Click Therapeutics
    • Happify Health
    • Headspace Health
    • Kaia Health
    • Livongo
    • my mhealth
    • Omada Health
    • Pear Therapeutics
    • Sidekick Health
    • Vida Health
    • Voluntis
    • Wise Therapeutics
    • Welldoc
  • Benchmark Industry Forecasts: Our forecasts for the current and future position of the digital therapeutics and wellness market, including the number of users, number of consumer wellness apps in use, number of employees enrolled in corporate wellness schemes, and total revenue, split by 30 countries:
    • Argentina
    • Australia
    • Brazil
    • Canada
    • China
    • Colombia
    • Denmark
    • India
    • Indonesia
    • Finland
    • France
    • Germany
    • Italy
    • Japan
    • Mexico
    • Netherlands
    • Nigeria
    • Norway
    • Pakistan
    • Poland
    • Portugal
    • Russia
    • Saudi Arabia
    • South Africa
    • Singapore
    • South Korea
    • Spain
    • Sweden
    • UK
    • US

Key Questions Answered

  1. What are the most promising emerging trends within the digital therapeutics and wellness space?
  2. What are the business models driving the digital therapeutics and wellness market?
  3. What are the biggest challenges facing stakeholders within the space?
  4. Which vendors are leading, challenging, and disrupting the market?
  5. How will the value of the digital therapeutics and wellness market grow over the next 5 years?

Companies Referenced

Interviewed: Sidekick Health, Voluntis, Wise Therapeutics.
Included in Juniper Research Competitor Leaderboard: 2Morrow, Big Health, Click Therapeutics, Happify Health, Headspace Health, Kaia Health, Livongo, my mhealth, Omada Health, Pear Therapeutics, Sidekick Health, Vida Health, Voluntis, Wise Therapeutics, Welldoc.
Mentioned: 3M, AbbVie, Accelmed, Adobe, American Diabetes Association, American Eagle, AptarGroup, ArrowMark Partners, Asabys Partners, AstraZeneca, AXA Venture Partners, Balderton Capital, Biocon Biologics, Blue Cross Blue Shield, Blue Shield of California, Boehringer Ingelheim, Boeing, Boston Medical, Bournemouth University , Bristol Myers Squibb, Caritas District of Columbia, Centene, Chiesi Group, Cigna, Cisco, Cleveland Clinic, Copado, Costco, Crossroads, CVS Health, Deerfield Management Company , Delta Air Lines, Dexcom, eBay, Eisai, Eurazeo, FDA, Fred Hutchinson Cancer Research Center, Frumtak Ventures, General Atlantic, GuideWell, H.I.G. BioHealth , Harvard School of Public Health, Higi, Home Depot, Humana, Innovate UK, ION Crossover Partners, JAMA Internal Medicine, Johnson & Johnson, Kaiser Permanente, LifeScan, Lilly, Magellan Health, Marvin, Medicaid, Merck Global Health Innovation Fund Ventures, Microsoft, NASDAQ, National Committee for Quality Assurance, NHS, Novartis, Novator , Oklahoma Health Care Authority, Omega Capital Partners, Optum Ventures, Orcha, Otsuka, Point32Health, Samsung, Sanofi, SoftBank, Solera Health, Stanford School of Medicine, Starbucks, Teladoc Health, The Hartford, Thimble Point Acquisition Corp, University of Maryland’s Center for Health Information and Decision System, University of Oxford, ViacomCBS, Visa, Vitality, Vodafone, Wellington Partners, WPS Health Insurance, WRF Capital, youturn.

Data & Interactive Forecast

Juniper Research’s Digital Therapeutics & Wellness forecast suite includes:

  • 5-year Digital Therapeutics benchmark forecasts for:
    • Number of People Using Therapeutics, Split by Region/Country
    • Number of People Using Therapeutics, Split by Addressed Condition
    • Number of People Using Therapeutics, Split by Payer
    • Total Therapeutics Revenue, Split by Region/Country
    • Total Therapeutics Revenue, Split by Addressed Condition
    • Total Therapeutics Revenue, Split by Payer
    • Number of People Using Digital Wellness Products, Split by Region/Country
    • Number of People Using Digital Wellness Products, Split by Market Segment
    • Total Digital Wellness Revenue, Split by Region/Country
    • Total Digital Wellness Revenue, Split by Market Segment
  • Access to the full set of forecast data of 220 tables and over 96,000 datapoints.
  • Interactive Excel Scenario tool allowing users to manipulate Juniper Research’s data for 4 different metrics.

Geographical splits: 30 countries

Harvest: Our online data platform, harvest, contains the very latest market data and is updated throughout the year. This is a fully featured platform enabling clients to better understand key data trends and manipulate charts and tables, overlaying different forecasts within the one chart - using the comparison tool. Empower your business with our market intelligence centre, and get alerted whenever your data is updated.

Interactive Excels (IFxl): Our IFxl tool enables clients to manipulate both forecast data and charts, within an Excel environment, to test their own assumptions using the Interactive Scenario Tool and compare selected markets side by side in customised charts and tables. IFxls greatly increase a clients’ ability to both understand a particular market and to integrate their own views into the model.

Forecast Summary

The research found that digital therapeutics revenue from health insurers will increase to $8 billion by 2026, up from $1.1 billion in 2022; representing a growth of 610% over the next four years.
  • Digital therapeutics facilitate the proactive mitigation of chronic medical conditions before they require costly interventions; enabling health insurers to reduce long-term costs per patient. However, these savings will be limited to health insurers in developed regions, where consumer devices and digitalised health infrastructure are ubiquitous. As such, health insurers in Africa and Latin America will contribute less than 2% towards health insurer-led digital therapeutics revenue in 2026.
  • Insurers will also benefit from an ongoing shift among digital therapeutics vendors towards engagement- and results-based payments. Digital therapeutics providers looking to leverage this trend should prioritise the development of performance benchmarks, as demonstrating improvement and preventing patient abandonment will become a direct monetary issue. 
  • The number of people using digital therapeutics will increase by 381% over the next four years. Machine learning will be key to this growth by facilitating advanced data analytics, remote patient monitoring, and real-time conversational coaching, however, an ongoing lack of standards surrounding the use of machine learning within digital therapeutics will result in vendors limiting its role in their offerings.
  • As developers and healthcare providers increasingly grapple with issues of liability and malpractice, machine learning will transition from a patient-facing role to a diagnostic tool offered through provider-facing dashboards; to be used by clinicians and specialists in a manner akin to traditional computer-aided diagnosti

Digital Therapeutics & Wellness Full Research Suite


Full Research Suite

  • Competitor leaderboard report (pdf)
  • Market trends & strategies report (pdf)
  • Market data, forecasts and analysis report (pdf)
  • Market data, forecasts and interactivity (xls)
  • harvest market data platform (12 months’ online access) - find out more

Click here for more information and purchase options

Annual Service




Research Details

Juniper Research
Adam Wears
Healthcare & Government
8 Key Regions - includes North America, Latin America, West Europe, Central & East Europe, Far East & China, Indian Subcontinent, Rest of Asia Pacific and Africa & Middle East
Argentina, Australia, Brazil, Canada, China, Colombia, Denmark, Finland, France, Germany, India, Indonesia, Japan, South Korea, Mexico, Netherlands, Nigeria, Norway, Pakistan, Poland, Portugal, Russian Federation, Saudi Arabia, Singapore, South Africa, Spain, Sweden, UK, USA